PD Dr. Corinna Lang-Schwarz



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Diagnostic Impact of Crypt Branching in Patients With Crohn's Disease: A Validation Study (2022) Lang-Schwarz C, Rubio CA, Vieth M Journal article Novel histological repertoire of crypt-associated anomalies in inflamed colon mucosa (2022) Rubio CA, Vieth M, Lang-Schwarz C Journal article Dysplastic Crypts in Asymmetric Branching in Ulcerative Colitis: A Preliminary Report (2022) Rubio CA, Vieth M, Lang-Schwarz C Journal article A red spot in the gut: The “floater” as a classic pitfall? Ein roter Fleck im Darm: Der „Floater“ als klassischer Pitfall? (2022) Lang-Schwarz C, Kiene R, Böcker I, Sterlacci W, Oellig F, Vieth M Journal article Diagnostic and Prognostic Impact of Crypt Branching in Patients With Ulcerative Colitis: A Validation Study (2022) Lang-Schwarz C, Rubio CA, Vieth M Journal article Branching crypts in inflammatory bowel disease revisited (2021) Rubio CA, Schmidt PT, Lang-Schwarz C, Vieth M Journal article, Review article Validation of the 'Inflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] Score' for Ulcerative Colitis and Crohn ' s Disease (2021) Lang-Schwarz C, Angeloni M, Agaimy A, Atreya R, Becker C, Dregelies T, Danese S, et al. Journal article Crypts in Asymmetric Fission in Endoscopic Biopsies from German Patients With Inflammatory Bowel Disease (2021) Rubio CA, Lang-Schwarz C, Vieth M Journal article Programmed death ligand 1 (PD-L1) in colon cancer and its interaction with budding and tumor-infiltrating lymphocytes (TILs) as tumor-host antagonists (2021) Lang-Schwarz C, Melcher B, Hartmann A, Bertz S, Dregelies T, Lang-Schwarz K, Vieth M, Sterlacci W Journal article Adjuvant chemotherapy in stage II and III colon cancer: the role of the "budding and TILs-(tumor-infiltrating lymphocytes) combination" as tumor-host antagonists (2021) Lang-Schwarz C, Melcher B, Dregelies T, Norouzzadeh Z, Rund-Kuffner S, Lang-Schwarz K, Sterlacci W, Vieth M Journal article
1 2 3 4